Amorfix suspends blood testing for vCJD
May 31, 2010 by leonardzehr · 1 Comment
Amorfix Life Sciences (TSX:AMF) has suspended development to commercialize its blood test for variant Creutzfeldt-Jakob disease (vCJD) after two new recently developed versions of the test did not yield positive results. “Although we were able to achieve unprecedented sensitivity with brain prions diluted into blood, we have been unable to detect blood prions with the [...]
Listen to BioTuesdays 
